Navigation Links
Oklahoma Blood Institute to Leverage BIO-key(R) Breakthrough TruDonor(TM) Fingerprint Donor Identification
Date:6/1/2010

WALL, N.J., June 1 /PRNewswire-FirstCall/ -- BIO-key International, Inc. (OTC Bulletin Board: BKYI), a leader in finger-based biometric identification solutions for the healthcare industry, today announced Oklahoma Blood Institute will deploy BIO-key's TruDonor biometric identification technology to enhance the convenience and security for blood donors later this year.  

(Logo: http://www.newscom.com/cgi-bin/prnh/20050509/BIOKEYLOGO)

Oklahoma Blood Institute (OBI), the twelfth largest non-profit regional blood center in America is incorporating BIO-key's patented fingerprint identification solution to provide blood donors with a fast and convenient method to establish their identity. This solution automates the donor check in process and protects donor privacy by eliminating the need for donors to produce sensitive identification forms, such as driver licenses or social security numbers. With just the simple touch of the donor's finger the software can search the OBI database to provide positive ID, reducing the check-in time and virtually eliminating human errors during the check-in process.

"At OBI, we recognize the importance of providing convenience for our donors and protecting their identity. Using the BIO-key ID solution, we are able to protect our donor's privacy while reducing the chance of duplicate donor IDs and aliases in our system," said John Armitage, M.D., Oklahoma Blood Institute president and chief executive. "We are constantly looking for ways to improve our donors' experiences and protect the inte
'/>"/>

SOURCE BIO-key International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology news :

1. University of Oklahoma study reveals red hot results
2. Environmental change impacts Oklahoma rivers
3. NSF awards $7.5M grant to University of Oklahoma for plant genomics
4. NSF awards Life in Transition grants to University of Oklahoma professors
5. National Science Foundation awards grant to Oklahoma structural biology group
6. National Science Foundations awards grant to Oklahoma structural biology group
7. Birds in Flint Hills of Kansas, Oklahoma face population decline despite large habitat
8. University of Oklahoma researcher named 2008 AAAS Fellow
9. Oklahoma EPSCoR receives $20 million for biofuels research
10. Oklahoma researchers support biodiversity in biofuels production
11. GM, Coskata partnership builds on Oklahoma State University biofuels research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... Dec. 15, 2014  HITLAB SM announced ... (GCP) audit to confirm its adherence to current ... accomplishment enables HITLAB to conduct regulated smart device ... principles for patient safety and research quality. ... access, quality, and delivery with innovative technology," said ...
(Date:12/17/2014)...  Automation is fundamentally transforming the travel experience ... international borders. Over the past decade, ePassports, biometric ... travelers to self process through border control via ... an increasing number of airports, seaports, and land ... to Maxine Most , Principal at Acuity ...
(Date:12/11/2014)... , Dec. 09, 2014 Research and ... ( http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has ... in India 2015-2019" report to their offering. ... this market is the adoption of multimodal biometric ... characteristic of an individual for verification and identification ...
Breaking Biology News(10 mins):HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... biologist is part of a team of researchers that has unlocked ... microscopic creatures. That first peek inside, recently published in the ... of the top three scientific journals in the world may ... the way it functions. "The organisms that live in soil ...
... Until today, Alfred Russell Wallace,s century old map from ... global biodiversity. Thanks to advances in modern technology and ... of Copenhagen have now produced a next generation map ... in Science Express today, the new map ...
... The Burgess Shale provides us with a rare glimpse into ... bones, teeth and shells but one of the most ... soft body structures like gills and eyes delicately preserved between the ... Shale has been giving us a unique perspective on what life ...
Cached Biology News:Biologists unlock 'black box' to underground world 2Wallace's century-old map of natural world updated 2
(Date:12/19/2014)... 2014 Naurex Inc., a biopharmaceutical company leveraging ... of the central nervous system, today announced that ... will present at the 33 rd annual J.P. ... at 3:00 p.m. PST on Tuesday, January 13, 2015, ... Francisco, Calif. About Naurex ...
(Date:12/19/2014)... CITY, Calif. , Dec. 19, 2014 Bina ... , USA) announced today that they have been acquired ... 1,2 is a privately held company that provides ... of next generation sequencing (NGS) data for the academic ... the Roche Sequencing Unit, and will continue to focus ...
(Date:12/19/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/fhh9rj/technology ) ... Innovations in Smart Fabrics (Technical Insights)" report ... http://photos.prnewswire.com/prnh/20130307/600769 The Research Service titled ... assessment on technological advancements and market for Smart ... 1. The Smart Fabrics market is expected to ...
(Date:12/19/2014)... Today, TiFiber, Inc. ... facility and future company headquarters in Fort Smith, ... materials that safely and effectively control dangerous microorganisms. ... its historic, strong support for manufacturing, but also ... edge, technology-based companies such as TiFiber. , ...
Breaking Biology Technology:Naurex to Present at 33rd Annual J.P. Morgan Healthcare Conference 2Bina Technologies is acquired by Roche. 2Bina Technologies is acquired by Roche. 3Technology Innovations in Smart Fabrics (Technical Insights) 2Technology Company TiFiber™ to Establish Production Facility in Fort Smith, Arkansas with Support from Local Investors 2Technology Company TiFiber™ to Establish Production Facility in Fort Smith, Arkansas with Support from Local Investors 3Technology Company TiFiber™ to Establish Production Facility in Fort Smith, Arkansas with Support from Local Investors 4
... Rapid Production, Increased Bioavailability, MOUNTAIN VIEW, Calif., ... are either incurable or difficult to treat allures ... prized, due to their,therapeutic potential, stem cell therapies ... Stem cell research progresses at a fast pace; ...
... Inc. (Nasdaq: CEPH ) and Eurand NV ... Paragraph IV Certification Notice Letter on October 20, ... to the U.S.,Food and Drug Administration (FDA) by ... a generic version of the 15 mg and,30 ...
... 71% of Evaluable Patients in the Trial,s First Stage ... Achieved Objective Tumor Responses- ... Second Stage-, TUSTIN, Calif., Oct. 21 Peregrine,Pharmaceuticals, Inc. (Nasdaq: ... cancer and serious viral,infections, today announced that updated preliminary data from ...
Cached Biology Technology:Innovation and Strong Therapeutic Potential Seen in Adult Stem Cells, According to Frost & Sullivan 2Innovation and Strong Therapeutic Potential Seen in Adult Stem Cells, According to Frost & Sullivan 3Cephalon and Eurand Announce Notification of Generic Filing for Cyclobenzaprine Hydrochloride Extended-Release Capsules 2Cephalon and Eurand Announce Notification of Generic Filing for Cyclobenzaprine Hydrochloride Extended-Release Capsules 3Cephalon and Eurand Announce Notification of Generic Filing for Cyclobenzaprine Hydrochloride Extended-Release Capsules 4Peregrine Pharmaceuticals Reports Progress in Its Phase II Trial of Bavituximab Plus Docetaxel in Patients With Advanced Breast Cancer 2Peregrine Pharmaceuticals Reports Progress in Its Phase II Trial of Bavituximab Plus Docetaxel in Patients With Advanced Breast Cancer 3Peregrine Pharmaceuticals Reports Progress in Its Phase II Trial of Bavituximab Plus Docetaxel in Patients With Advanced Breast Cancer 4